Chronic Condition Management

Rep. Greg Murphy, MD (R-North Carolina), discusses reforms he hopes Congress will consider this year.

Agency projects major health effects for the better if nicotine amount is reduced to nonaddictive levels.

Clinical and preclinical are distinctions that could guide patient treatment, public health and medical policy going forward, according to study commission.

Rep. Greg Murphy, MD (R-North Carolina), discusses reforms he hopes Congress will consider this year.

The collaboration enables eligible customers to find and enroll in health benefits directly through Amazon.

Evidence is uncertain about effectiveness of screening in men.

A new study estimates that Americans are twice as likely to be diagnosed with dementia than previously believed.

Practical strategies for delivering life-changing news with empathy and expertise.

A policy scenario to lower nicotine in tobacco products was published during the first Trump administration. FDA may be poised to bring it back for more consideration.

It’s not too late to make a new year’s resolution to eat better. Here’s some good advice on eating for patients and physicians.

A recent study found that many patients are left waiting to see a neurologist for more than a month after they are referred.

Technology is great, but humans are the key to healthy patients

A recent systematic review analyzed the use of Brief Geriatric Assessments (BGAs) as a tool for screening older adults in primary care settings.

Physical inactivity is a major risk factor for several chronic health conditions and should set off red flags during primary care visits.

Recommendations and resources from U.S. Surgeon General Vivek Murthy, MD, MBA.

New advisory lists evidence and recommends more public awareness of increased cancer risk from beer, wine and spirits.

A slideshow with conversation starters for physicians and patients to evaluate factors affecting brain health at the start of a new year.

Patients hospitalized by physicians with higher admission rates are likelier to be discharged within 24 hours but no less likely to die.

Guidelines developed by an expert workgroup are the first of their kind in more than two decades, and the first ever applicable to primary care settings.

Zepbound is the first and only prescription medication indicated for adults with moderate-to-severe obstructive sleep apnea and obesity.

New statement aims to ensure access to tirzepatide as other GLP-1 drug shortages persist.

New research demonstrates the impact that long COVID has on patients' physical, emotional and financial well-being.

Despite its potential to improve quality of life, palliative care remains underused in stroke recovery, especially among Black, Hispanic and Asian populations.

Respondents citing financial hardship as a reason for non-adherence to asthma medications had nearly double the odds of an asthma attack and more than 60% heightened risk of requiring ED care.

Early screening for cancer is critical and PCPs play a major role in educating patients about regular screenings.

How is life different across the pond? UK babies can expect to live longer than newborn Americans.

The cost-effectiveness of using AI-ECG is $27,858 per quality-adjusted life year, and it’s particularly cost-effective in outpatient settings.

The regulatory battle over compounded semaglutide and health effects on the heart are among latest developments involving GLP-1 RA drugs.

Robert Kushner, MD, an expert in overweight, obesity, nutrition, diet and exercise, discusses the effects of the new antiobesity medications.

PCORI announces list of grants to support studies on patient-centered health care.